FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Ciba Found Symp / Clinical uses of hyaluronan.
Ciba Foundation symposium1989; 143; 265-285; doi: 10.1002/9780470513774.ch16

Clinical uses of hyaluronan.

Abstract: The availability of elastoviscous solutions of highly purified hyaluronan has created two new therapeutic methods in human and veterinary medicine: viscosurgery and viscosupplementation. Viscosurgical tools and implants are widely used in ophthalmology and have been suggested for use in otology. Visco-supplementation of joint fluid using elastoviscous hyaluronan solutions is widely used in the treatment of equine traumatic arthritis. It was also suggested for use in idiopathic osteoarthritis in humans, but this application has not received wide acceptance. Cross-linked forms of hyaluronan have been developed and given the generic name of hylans. Water-insoluble soft gels of hylans are ideally suitable as viscosurgical implants to prevent postoperative adhesions and to control scar formation. Hylan solutions are being used in arthroscopic viscosurgery. Hylan devices in various forms (gels, tubes, membranes) have been used in animal studies for matrix engineering, the purpose of which is to control and direct tissue regeneration and augmentation.
Get Full Text
Publication Date: 1989-01-01 PubMed ID: 2680347DOI: 10.1002/9780470513774.ch16Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research focuses on the clinical uses of highly purified hyaluronan, particularly in viscosurgery and viscosupplementation, fields of human and veterinary medicine. These techniques are prevalent in ophthalmology and equine arthritis treatment, and have potential implementation in other areas.

Hyaluronan and Its Therapeutic Potentials

  • Hyaluronan, a highly purified viscous solution, has seen recent therapeutic use in two major areas: viscosurgery, a type of surgery that uses viscous solutions for surgical procedures, and viscosupplementation, a procedure that increases joint fluidity using viscous solutions.
  • The availability of this highly purified substance has brought forth new possibilities in both human and veterinary medicine. Some of the key areas discussed in this paper include ophthalmology, otology, arthritis treatment, and matrix engineering.

Uses in Ophthalmology and Otology

  • Viscosurgical tools and implants made with hyaluronan solutions are extensively used in ophthalmology. This is because the viscous solutions of hyaluronan prove beneficial in such delicate surgical procedures.
  • The use of hyaluronan is also suggested in otology, though the paper does not detail this application much.

Uses in Arthritis Treatment

  • Viscosupplementation of joint fluid with hyaluronan solutions has found wide acceptance in the treatment of equine traumatic arthritis. This helps to enhance fluidity in the joints, thus benefiting the patients.
  • Whilst this method has been suggested for use in humans with idiopathic osteoarthritis, it hasn’t seen widespread acceptance yet.

Development of Hylans and Their Uses

  • The researchers have developed cross-linked forms of hyaluronan, named as hylans. Hylans are soft, water-insoluble gels ideally suitable for use as implants in viscosurgery.
  • Hylan solutions have found their application in arthroscopic viscosurgery, a minimally invasive surgical procedure on a joint.
  • In animal studies, hylan devices in the form of gels, tubes, and membranes have been used for matrix engineering. The aim is to control and direct tissue regeneration and augmentation, leading to improved healing and recovery.

Cite This Article

APA
Balazs EA, Denlinger JL. (1989). Clinical uses of hyaluronan. Ciba Found Symp, 143, 265-285. https://doi.org/10.1002/9780470513774.ch16

Publication

Ciba Foundation symposium
ISSN: 0300-5208
NlmUniqueID: 0356636
Country: Netherlands
Language: English
Volume: 143
Pages: 265-285

Researcher Affiliations

Balazs, E A
  • Matrix Biology Institute, Ridgefield, NJ 07657.
Denlinger, J L

    MeSH Terms

    • Animals
    • Humans
    • Hyaluronic Acid / therapeutic use
    • Surgical Procedures, Operative / methods

    Citations

    This article has been cited 32 times.
    1. Magdziarz S, Boguń M, Frączyk J. Coating Methods of Carbon Nonwovens with Cross-Linked Hyaluronic Acid and Its Conjugates with BMP Fragments. Polymers (Basel) 2023 Mar 21;15(6).
      doi: 10.3390/polym15061551pubmed: 36987331google scholar: lookup
    2. Garantziotis S. Modulation of hyaluronan signaling as a therapeutic target in human disease. Pharmacol Ther 2022 Apr;232:107993.
      doi: 10.1016/j.pharmthera.2021.107993pubmed: 34587477google scholar: lookup
    3. Wolf KJ, Kumar S. Hyaluronic Acid: Incorporating the Bio into the Material. ACS Biomater Sci Eng 2019 Aug 12;5(8):3753-3765.
      doi: 10.1021/acsbiomaterials.8b01268pubmed: 31598545google scholar: lookup
    4. D'Agostino A, Maritato R, La Gatta A, Fusco A, Reale S, Stellavato A, Pirozzi AVA, De Rosa M, Donnarumma G, Schiraldi C. In Vitro Evaluation of Novel Hybrid Cooperative Complexes in a Wound Healing Model: A Step Toward Improved Bioreparation. Int J Mol Sci 2019 Sep 24;20(19).
      doi: 10.3390/ijms20194727pubmed: 31554177google scholar: lookup
    5. Garantziotis S, Savani RC. Hyaluronan biology: A complex balancing act of structure, function, location and context. Matrix Biol 2019 May;78-79:1-10.
      doi: 10.1016/j.matbio.2019.02.002pubmed: 30802498google scholar: lookup
    6. Philipp-Dormston WG. [Hyaluronic acid fillers in dermatology]. Hautarzt 2018 Jun;69(6):491-509.
      doi: 10.1007/s00105-018-4168-8pubmed: 29850921google scholar: lookup
    7. Longinotti C. The use of hyaluronic acid based dressings to treat burns: A review. Burns Trauma 2014;2(4):162-8.
      doi: 10.4103/2321-3868.142398pubmed: 27602379google scholar: lookup
    8. DuFort CC, DelGiorno KE, Hingorani SR. Mounting Pressure in the Microenvironment: Fluids, Solids, and Cells in Pancreatic Ductal Adenocarcinoma. Gastroenterology 2016 Jun;150(7):1545-1557.e2.
      doi: 10.1053/j.gastro.2016.03.040pubmed: 27072672google scholar: lookup
    9. Caires R, Luis E, Taberner FJ, Fernandez-Ballester G, Ferrer-Montiel A, Balazs EA, Gomis A, Belmonte C, de la Peña E. Hyaluronan modulates TRPV1 channel opening, reducing peripheral nociceptor activity and pain. Nat Commun 2015 Aug 27;6:8095.
      doi: 10.1038/ncomms9095pubmed: 26311398google scholar: lookup
    10. Kawada C, Yoshida T, Yoshida H, Matsuoka R, Sakamoto W, Odanaka W, Sato T, Yamasaki T, Kanemitsu T, Masuda Y, Urushibata O. Ingested hyaluronan moisturizes dry skin. Nutr J 2014 Jul 11;13:70.
      doi: 10.1186/1475-2891-13-70pubmed: 25014997google scholar: lookup
    11. Tamer TM. Hyaluronan and synovial joint: function, distribution and healing. Interdiscip Toxicol 2013 Sep;6(3):111-25.
      doi: 10.2478/intox-2013-0019pubmed: 24678248google scholar: lookup
    12. Nikitovic D, Kouvidi K, Karamanos NK, Tzanakakis GN. The roles of hyaluronan/RHAMM/CD44 and their respective interactions along the insidious pathways of fibrosarcoma progression. Biomed Res Int 2013;2013:929531.
      doi: 10.1155/2013/929531pubmed: 24083250google scholar: lookup
    13. De Boulle K, Glogau R, Kono T, Nathan M, Tezel A, Roca-Martinez JX, Paliwal S, Stroumpoulis D. A review of the metabolism of 1,4-butanediol diglycidyl ether-crosslinked hyaluronic acid dermal fillers. Dermatol Surg 2013 Dec;39(12):1758-66.
      doi: 10.1111/dsu.12301pubmed: 23941624google scholar: lookup
    14. Mainil-Varlet P, Schiavinato A, Ganster MM. Efficacy Evaluation of a New Hyaluronan Derivative HYADD(®) 4-G to Maintain Cartilage Integrity in a Rabbit Model of Osteoarthritis. Cartilage 2013 Jan;4(1):28-41.
      doi: 10.1177/1947603512455193pubmed: 23550192google scholar: lookup
    15. Provenzano PP, Hingorani SR. Hyaluronan, fluid pressure, and stromal resistance in pancreas cancer. Br J Cancer 2013 Jan 15;108(1):1-8.
      doi: 10.1038/bjc.2012.569pubmed: 23299539google scholar: lookup
    16. Provenzano PP, Cuevas C, Chang AE, Goel VK, Von Hoff DD, Hingorani SR. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 2012 Mar 20;21(3):418-29.
      doi: 10.1016/j.ccr.2012.01.007pubmed: 22439937google scholar: lookup
    17. Shahrabi Farahani S, Sexton J, Stone JD, Quinn K, Woo SB. Lip nodules caused by hyaluronic acid filler injection: report of three cases. Head Neck Pathol 2012 Mar;6(1):16-20.
      doi: 10.1007/s12105-011-0304-9pubmed: 21984020google scholar: lookup
    18. . What's New in Fillers in 2010?. J Clin Aesthet Dermatol 2010 Aug;3(8):36-45.
      pubmed: 20877541
    19. Gold MH. Soft tissue augmentation in dermatology - 2009 update. J Cutan Aesthet Surg 2010 Jan;3(1):2-10.
      doi: 10.4103/0974-2077.63220pubmed: 20606985google scholar: lookup
    20. Toole BP. Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities. Clin Cancer Res 2009 Dec 15;15(24):7462-7468.
      doi: 10.1158/1078-0432.CCR-09-0479pubmed: 20008845google scholar: lookup
    21. Park JB, Kwak HJ, Lee SH. Role of hyaluronan in glioma invasion. Cell Adh Migr 2008 Jul-Sep;2(3):202-7.
      doi: 10.4161/cam.2.3.6320pubmed: 19262113google scholar: lookup
    22. Angele P, Müller R, Schumann D, Englert C, Zellner J, Johnstone B, Yoo J, Hammer J, Fierlbeck J, Angele MK, Nerlich M, Kujat R. Characterization of esterified hyaluronan-gelatin polymer composites suitable for chondrogenic differentiation of mesenchymal stem cells. J Biomed Mater Res A 2009 Nov;91(2):416-27.
      doi: 10.1002/jbm.a.32236pubmed: 18985778google scholar: lookup
    23. Brandt FS, Cazzaniga A. Hyaluronic acid gel fillers in the management of facial aging. Clin Interv Aging 2008;3(1):153-9.
      doi: 10.2147/cia.s2135pubmed: 18488885google scholar: lookup
    24. Gold MH. Use of hyaluronic acid fillers for the treatment of the aging face. Clin Interv Aging 2007;2(3):369-76.
      doi: 10.2147/cia.s1244pubmed: 18044187google scholar: lookup
    25. Gunaydin S, Mccusker K, Vijay V. Clinical performance and biocompatibility of novel hyaluronan-based heparin-bonded extracorporeal circuits. J Extra Corpor Technol 2005 Sep;37(3):290-5.
      pubmed: 16350383
    26. Strachan RK, Smith P, Gardner DL. Hyaluronate in rheumatology and orthopaedics: is there a role?. Ann Rheum Dis 1990 Nov;49(11):949-52.
      doi: 10.1136/ard.49.11.949pubmed: 2256748google scholar: lookup
    27. McCracken JM, Calderon GA, Rivas F, Erxleben D, Moseley T, Kumar LA, Kennedy DE 2nd, Balaji S, Hall A, Hakim JCE. Unveiling Vaginal Fibrosis: A Novel Murine Model Using Bleomycin and Epithelial Disruption. Open J Obstet Gynecol 2025 Mar;15(3):371-386.
      doi: 10.4236/ojog.2025.153033pubmed: 40895506google scholar: lookup
    28. van Setten GB. Cellular Stress in Dry Eye Disease-Key Hub of the Vicious Circle. Biology (Basel) 2024 Aug 28;13(9).
      doi: 10.3390/biology13090669pubmed: 39336096google scholar: lookup
    29. Kanclerz P, Bazylczyk N, Radomski SA. Tear film stability in patients with symptoms of dry eye after instillation of dual polymer hydroxypropyl guar/sodium hyaluronate vs single polymer sodium hyaluronate. Int Ophthalmol 2024 Apr 24;44(1):193.
      doi: 10.1007/s10792-024-03061-5pubmed: 38653918google scholar: lookup
    30. Liao Z, Umar M, Huang X, Qin L, Xiao G, Chen Y, Tong L, Chen D. Transient receptor potential vanilloid 1: A potential therapeutic target for the treatment of osteoarthritis and rheumatoid arthritis. Cell Prolif 2024 Mar;57(3):e13569.
      doi: 10.1111/cpr.13569pubmed: 37994506google scholar: lookup
    31. Boissier P, Mainil-Varlet P, Mautone GR. Increasing Concentration of Sinovial: Effect on Cartilage Protection in a Rabbit ACLT Model. Cartilage 2021 Dec;13(2_suppl):185S-195S.
      doi: 10.1177/1947603520905363pubmed: 32070117google scholar: lookup
    32. Şahin Ş, Tuncel SA, Salimi K, Bilgiç E, Korkusuz P, Korkusuz F. Advanced Injectable Alternatives for Osteoarthritis. Adv Exp Med Biol 2018;1077:183-196.
      doi: 10.1007/978-981-13-0947-2_11pubmed: 30357690google scholar: lookup
    Subscribe to our newsletter
    Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.